5-HT3 receptor modulators, methods of making, and use thereof

Details for Australian Patent Application No. 2009260469 (hide)

Owner Albany Molecular Research, Inc.

Inventors Manning, David D.; Cioffi, Christopher L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009260469

PCT Pub. Number WO2009/155054

Priority 61/057,014 29.05.08 US

Filing date 28 May 2009

Wipo publication date 23 December 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/155054 Priority application(s): WO2009/155054

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009260471-Non-hormonal steroid modulators of NF-KB for treatment of disease

2009260465-Wind diverter